CN103893694B - A kind of medicine for treating coronary heart disease - Google Patents

A kind of medicine for treating coronary heart disease Download PDF

Info

Publication number
CN103893694B
CN103893694B CN201410100271.4A CN201410100271A CN103893694B CN 103893694 B CN103893694 B CN 103893694B CN 201410100271 A CN201410100271 A CN 201410100271A CN 103893694 B CN103893694 B CN 103893694B
Authority
CN
China
Prior art keywords
medicine
boiled
liquid
storax
tuber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410100271.4A
Other languages
Chinese (zh)
Other versions
CN103893694A (en
Inventor
常风云
李国庆
侯朝阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebi College of Vocation and Technology
Original Assignee
Hebi College of Vocation and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebi College of Vocation and Technology filed Critical Hebi College of Vocation and Technology
Priority to CN201410100271.4A priority Critical patent/CN103893694B/en
Publication of CN103893694A publication Critical patent/CN103893694A/en
Application granted granted Critical
Publication of CN103893694B publication Critical patent/CN103893694B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of medicine for treating coronary heart disease.The amounts of components of the medicine is:The 8g of American Ginseng 4, the 22g of the Radix Astragali 18, the 17g of the red sage root 13, the 5g of leech 1, the 0.5g of storax 0.1, the 12g of Exocarpium Citri Rubrum 8, the 12g of Longstamen Onion Bulb 8, the 12g of almond 8, the 32g of Snakegourd Fruit 28, the 5g of the tuber of pinellia 1, the 17g of Ligusticum wallichii 13, the 14g of Radix Angelicae Sinensis 10, the 14g of rhizoma cyperi 10 and the 12g of root tuber of aromatic turmeric 8;Its manufacture craft is:Said medicine is put into medicine pot, is soaked 1 hour and is started to boil, it is first boiled with big fire, then boiled 40 minutes with small fire, liquid is leached.Add water again and boiled, boil the time 20 minutes, leach liquid, will twice liquid mix, add the 0.4g of storax 0.2, stir finished product.The present invention is formulated as a result of several kinds of Chinese medicinal materials, and its product includes multi-medicament composition, rapid-action, take that crowd is wide, medicine stability is good, evident in efficacy, and more after without recurrence, have no toxic side effect, relieve the trouble and worry of patient.

Description

A kind of medicine for treating coronary heart disease
Technical field:The present invention relates to a kind of Chinese patent medicine preparation, heart equilibrium between yin and yang is specifically nursed one's health, reach treatment coronary disease A kind of medicine for treating coronary heart disease that sick mesh ground is taken.
Background technology:With the improvement of people's living standards, people put physical condition in critical positions.But The high nutrition of the modern life is superfluous, various rich man's diseases is susceptible to suffer from, so as to form coronary disease illness.Coronary heart disease is the common of today's society Disease, doctor trained in Western medicine thinks bad life style, phlegm-dampness constitution, overfeeding greasy and surfeit flavour, stress is excessive is to cause the main of the disease Reason.The category of the disease such as coronary heart disease traditional Chinese medical science category " angina pectoris ", " pained ", " obstruction of qi in the chest ", " exhaustion of vital energy at the critical stage of an illness " " phlegm stagnation ", heart governing blood and vessels, The heart qi deficiency then powerless operation for agitating painstaking effort;Phlegm stagnation, blood viscousness, blood is puckery obstructed to be made blood operation difficult and chest occurs Bitterly, myocardial ischemia or necrosis;Disease development, pathogen being excessive but vital QI weak, hemostasis is aggravated, and the stasis of blood is stagnant heavier, healthy tendency callus.And coronary disease is treated now The medicine of illness, major part has toxic and side effect, and expensive, and therapeutic effect is undesirable.
The content of the invention:The present invention is directed to the deficiencies in the prior art, there is provided one kind has QI invigorating, promoting blood circulation, promoting the circulation of qi A kind of medicine for treating coronary heart disease of function.
The technical scheme that is used to achieve the above object of the present invention is:The amounts of components of the medicine is:American Ginseng 4-8g, Radix Astragali 18-22g, red sage root 13-17g, leech 1-5g, storax 0.1-0.5g (taking after mixing it with water), Exocarpium Citri Rubrum 8-12g, Longstamen Onion Bulb 8-12g, almond 8-12g, Snakegourd Fruit 28-32g, tuber of pinellia 1-5g, Ligusticum wallichii 13-17g, Radix Angelicae Sinensis 10-14g, rhizoma cyperi 10-14g and root tuber of aromatic turmeric 8-12g;It makes Technique is:Said medicine is put into medicine pot, adding water must be higher by medicine top levels 3cm, soaked 1 hour, start to boil, first used Big fire is boiled, is then boiled 40 minutes with small fire, and liquid is leached, and liquid 200ml is endured out first.Add water again and be higher by medicine top Portion horizontal plane 2cm, is boiled, and boils the time 20 minutes, leaches liquid 200ml, liquid will be mixed twice, adds storax 0.2-0.4g, stir finished product, in last filling and package bag, refrigeration storage.
Theory of traditional Chinese medical science thinks that among blood vessels, circulation is more than, flows round without stopping for blood operation.《Longevity and Life Preservation》Say:" gas is With the passing of time and blood the general of blood, the obstruction of the circulation of vital energy.Gas has respiration not transport, then blood has the respiration not all right ".So syndrome of blood stasis is inevitably involved Gas, can cause gas not promoting circulation of blood because of the deficiency of vital energy or the stagnation of the circulation of vital energy, form coronary heart disease, and coronary heart disease is then long-term chronic deeline, is five The dirty unbalanced external manifestation of six internal organs, belongs to tcm internal medicine apoplexy category.According to the interpretation of the cause, onset and process of an illness of coronary heart disease, face card treatment with QI invigorating, Promoting blood circulation, the method for promoting the circulation of qi.
The present invention combines coronary heart disease clinic common sympton, breaks current conventional treatments, is with traditional Chinese medical theory Basis, studies through clinical observation for many years, to the continuous Improvement of prescription, modification supplement, and according to its pathogenesis, takes and dispels The treatment of evil righting.Reinforced vital energy with American Ginseng, the Radix Astragali in side, gas row then blood, and stagnation resolvation without wound just;The red sage root, leech, when Return promoting blood circulation and removing blood stasis stimulating the menstrual flow;The tuber of pinellia, Exocarpium Citri Rubrum, longstamen onion bulb and the almonds, Snakegourd Fruit resolving sputum, profit gas dissipating bind also simultaneous are relaxed bowel with chest wide;Soviet Union Blending is walked to alter, sensible to open strongly fragrant, degrading the channel;Root tuber of aromatic turmeric, rhizoma cyperi, the Ligusticum wallichii promoting flow of qi and blood circulation, to help blood.Full side play altogether righting QI invigorating, Promoting blood circulation and removing blood stasis, promoting qi circulation and relieving pain work(.
The beneficial effects of the invention are as follows:Be formulated as a result of several kinds of Chinese medicinal materials, its product include multi-medicament into Part, it is rapid-action, take that crowd is wide, medicine stability is good, be easy to carry, it is evident in efficacy, can rapidly cure coronary disease illness, and more after Without recurrence, have no toxic side effect, relieve the trouble and worry of patient.
1st, our tonifying yin yang-tonifying, nurses one's health the vital organs of the human body, makes up to new dynamic equilibrium, positive fate and general mood self-healing.Have The effect of shadow is shown in vertical rod, can be widely used for clinic.
2nd, the our true essence for obtaining Zhong Jing, mends the side of colluding, and coronary heart disease is significantly taken on a new look in 2 years 1 year mostly.Effectively improve life Life quality, determined curative effect, manufacture craft is simple, low cost, cheap.It is painless after medication due to being made of Chinese herb medicine It is bitter, do not rebound.
3rd, Small side effects, safe and reliable, the medicine of general western medical treatment coronary heart disease has dizzy, headache, and Nausea and vomiting is closed The side effects such as section pain, constipation, hepatic disorder, and Long-term taking medicine is needed, easily recurred after drug withdrawal, and controlled using the party Treat, patient's reflection is good, 94% conditions of patients is cured or is clearly better, and from clinical observation, this can reduce AMI patients serums The levels of Ang II.PIIINP.ALD and TGF β 1, increased SOD level, and LVEDV and LVEF can be obviously improved, can substantially reduce Clinical symptoms and syndrome of qi stagnation and blood stasis are integrated, and mitigate clinical symptoms, improve late result, improve heart function, and have no toxic side effect Generation.
Specific embodiment:Embodiment 1, the amounts of components of the medicine is:American Ginseng 4-8g, Radix Astragali 18-22g, red sage root 13- 17g, leech 1-5g, storax 0.1-0.5g, Exocarpium Citri Rubrum 8-12g, Longstamen Onion Bulb 8-12g, almond 8-12g, Snakegourd Fruit 28-32g, tuber of pinellia 1- 5g, Ligusticum wallichii 13-17g, Radix Angelicae Sinensis 10-14g, rhizoma cyperi 10-14g and root tuber of aromatic turmeric 8-12g;Its manufacture craft is:Said medicine is put into medicine Pot, adding water must be higher by medicine top levels 3cm, soak 1 hour, start to boil, first boiled with big fire, then be boiled with small fire 40 minutes, liquid is leached, liquid 200ml is endured out first.Add water again and be higher by medicine top levels 2cm, boiled, endure 20 minutes time processed, leach liquid 200ml, will twice liquid mix, add storax 0.2-0.4g, stir into Product, in last filling and package bag, refrigeration storage.
Embodiment 2:The amounts of components of described medicine is:American Ginseng 6g, Radix Astragali 20g, red sage root 15g, leech 3g, storax 0.3g, Exocarpium Citri Rubrum 10g, Longstamen Onion Bulb 10g, almond 10g, Snakegourd Fruit 30g, tuber of pinellia 3g, Ligusticum wallichii 15g, Radix Angelicae Sinensis 12g, rhizoma cyperi 12g and root tuber of aromatic turmeric 10g; Its manufacture craft is:Said medicine is put into medicine pot, adding water must be higher by medicine top levels 3cm, soaked 1 hour, start to endure System, it is first boiled with big fire, then boiled 40 minutes with small fire, liquid is leached, liquid 200ml is endured out first.Add water height again Go out medicine top levels 2cm, boiled, boil the time 20 minutes, leach liquid 200ml, liquid will mix twice, add Storax 0.3g, stir finished product, in last filling and package bag, refrigeration storage.
Embodiment 3:This drug administration method is serviced once for a point morning and evening, is continuously taken 2 months.Coronary disease patient can be made to recover strong Health, and do not recur for many years.
Embodiment 4:Criterion of therapeutical effect
(1) heart function detection:Using echocardiography.
(2) biochemical indicator:Angiotensin II (Ang II), transforminggrowthfactor-β1 (TGF β 1), superoxide dismutase Enzyme (SOD), serum type III procollagen amino terminal peptide (PIIINP), aldosterone (ALD) detection AngII, PIIINP, ALD.
(3) qi depression to blood stasis integration:Symptom by without, it is light, in, weight degree remember 0,1,2,3 point respectively.
Heart function detection, biochemical indicator are healing in normal range (NR);It is obviously improved earlier above, close to normal to take a turn for the better, nothing changes It is apt to as invalid.Qi depression to blood stasis is integrated, and symptom disappears to cure, and symptom substantially mitigates to take a turn for the better, invalid without being improved as.
Embodiment 5:Clinical observation and curative effect
This group of case is 86 AMI that in June, 2011 to the Hebi City of in July, 2013 the People's Hospital Cardiological accepts for medical treatment and suffers from Person, 86 meet syndrome of qi stagnation and blood stasis diagnostic criteria, and observation group and each 43 of control group are divided into by table of random number.Observation group man Property 25, women 18;Year at age (62.4 ± 7.3);Control group male 26, women 17;Year at age (61.4 ± 7.1). Two groups of patient's physical data compare no difference of science of statistics, with comparativity.
Syndrome of qi stagnation and blood stasis diagnostic criteria:Reference《Chest impediment and cardialgia (coronary disease and angina pectoris) suddenly demonstrate,proves diagnosis and treatment specification》Formulate, receive people Standard:1. the Diagnosis of Acute Myocardial Infarction standard that myocardial ischemia, ST section are raised is met;2. syndrome of qi stagnation and blood stasis diagnostic criteria is met; 3. NYHA heart functions I~III level;4. age < 75 years old;5. informed consent is obtained.
We treat 43 altogether, and by 2 months medication treatments, clinical cure 25 accounted for 58%, and effective 16 account for 37%, nothing Effect 2 accounts for 5%, total effective rate 95%.Two groups of forward and backward parameters of left ventricular function for the treatment of compare:Observation group LVDd, LVEDV after treatment, LVSDV, CI and LVEF are obviously improved (P < 0.05, P < 0.01) before relatively treating, and control group LVEDV, LVSDV and LVEF are relatively controlled Improve (P < 0.05, P < 0.01) before treating;The improvement of observation group LVEDV and LVEF is better than control group (P < 0.05).
Embodiment 6:Patient proves
Patient, man, 65 years old, suffers from coronary heart disease for many years, weakness of limbs, and heart often twists pain, and myocardial ischemia is infused with Western medicine, 1 year twice, without basic improvement.Take this formula three months, blood fat is obviously improved, heart tends to be steady after six months, heart Do not ache, take 1 year no relapse phenomenon, it is still normal to chemically examine so far.
Patient, man 52 years old, suffers from coronary heart disease, and myocardial ischemia, a dizzy heartbeat 4 years is precious through the distressed fixed, heart of informal dress, red sage root drop The medicines such as ball, without basic improvement, take this formula, and six months dizzy heartbeats are steady, no relapse phenomenon.
Patient, female 72 years old, suffers from coronary heart disease, and myocardial ischemia, the big finger of hand and secondary finger are numb, it is impossible to hold thing, transfusion in a year is twice Prevention, without basic improvement, takes this formula, and blood pressure is steady within eight months, and pain and numbness disappears, no relapse phenomenon.

Claims (1)

1. a kind of medicine for treating coronary heart disease, it is characterised in that the bulk drug amounts of components of described medicine is:American Ginseng 6g, Huang Stilbene 20g, red sage root 15g, leech 3g, storax 0.3g, Exocarpium Citri Rubrum 10g, Longstamen Onion Bulb 10g, almond 10g, Snakegourd Fruit 30g, tuber of pinellia 3g, Ligusticum wallichii 15g, Radix Angelicae Sinensis 12g, rhizoma cyperi 12g and root tuber of aromatic turmeric 10g;Its manufacture craft is:Said medicine outside storax is put into medicine pot, add water palpus Medicine top levels 3cm is higher by, is soaked 1 hour, start to boil, it is first boiled with big fire, then boiled 40 minutes with small fire, will Liquid is leached, and liquid 200ml is endured out first, adds water be higher by medicine top levels 2cm again, is boiled, and boils the time 20 Minute, leach liquid 200ml, liquid will mix twice, add storax 0.3g, stir finished product, it is last filling In packaging bag, refrigeration storage.
CN201410100271.4A 2014-03-11 2014-03-11 A kind of medicine for treating coronary heart disease Expired - Fee Related CN103893694B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410100271.4A CN103893694B (en) 2014-03-11 2014-03-11 A kind of medicine for treating coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410100271.4A CN103893694B (en) 2014-03-11 2014-03-11 A kind of medicine for treating coronary heart disease

Publications (2)

Publication Number Publication Date
CN103893694A CN103893694A (en) 2014-07-02
CN103893694B true CN103893694B (en) 2017-06-06

Family

ID=50985478

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410100271.4A Expired - Fee Related CN103893694B (en) 2014-03-11 2014-03-11 A kind of medicine for treating coronary heart disease

Country Status (1)

Country Link
CN (1) CN103893694B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111437358A (en) * 2019-01-16 2020-07-24 辽宁中医药大学 Traditional Chinese medicine composition for treating atherosclerosis caused by phlegm-turbidity and blood stasis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1593489A (en) * 2004-07-02 2005-03-16 李东林 Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120263809A1 (en) * 2011-03-29 2012-10-18 Andrew Baker Nutritional Supplement Comprising Nut and Seed Oil Composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1593489A (en) * 2004-07-02 2005-03-16 李东林 Traditional Chinese Medicinal formulation for treating coronary heart disease and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"从一病一基本方"谈辨病与辨证相结合;金丽;《甘肃中医》;20021231;第15卷(第1期);第39-40页尤其是第39页右栏第2-3段,第40页左栏倒数5-8行 *
胸痹心痛证治体会;陶克文;《实用中医药杂志》;19941231(第3期);第3页左栏第2段第1行,倒数第2-5行 *

Also Published As

Publication number Publication date
CN103893694A (en) 2014-07-02

Similar Documents

Publication Publication Date Title
CN103405668B (en) Medicament for treating arrhythmia
CN104758587A (en) Traditional Chinese medicine composition for treating arrhythmia
CN104013849A (en) Traditional Chinese medicinal composition for treating hypertension and preparation method thereof
CN109010468A (en) Antitumor Chinese and its preparation method and application based on ancient prescription Tuoli Xiaodu
CN104547939A (en) Traditional Chinese medicine preparation for treating premature beat
CN103893694B (en) A kind of medicine for treating coronary heart disease
CN102631538A (en) Traditional Chinese medicine for treating heart disease
CN102198181B (en) Antithrombotic and thrombosis-eliminating preparation
CN101716236B (en) Chinese medicinal composition for adjunctively treating left ventricular insufficiency after acute myocardial infarction and preparation method thereof
CN105055967B (en) A kind of complex health care product and preparation method with auxiliary hyperglycemic function
CN104435545B (en) A kind of Chinese medicine preparation for treating caused by benzene leukopenia
CN102048939A (en) Medicament for treating sinus bradycardia
CN103055122B (en) The medicine and preparation method thereof of restenosis after prevention percutaneous transluminal coronary stent implantation
CN101530595B (en) Thrombolysis decoction for treating cardiovascular diseases
CN105477330A (en) Traditional Chinese medicine composition for treating arrhythmia
CN104127670A (en) Traditional Chinese medicine decoction for treating arrhythmia
CN107669836A (en) Coronary disease and angina pectoris Chinese medicine preparation and preparation method thereof
CN104173494B (en) A kind of Chinese medicine preparation treating coronary heart disease
CN103417794B (en) Chinese herbal preparation for treating chronic congestive heart failure
CN112206279B (en) Traditional Chinese medicine composition for treating ventricular arrhythmia and preparation method and application thereof
CN103230443B (en) Treat hypertensive Chinese medicine composition
CN103028088B (en) Traditional Chinese medicine composition for treating coronary heart disease and angina
CN101983712A (en) Novel medicament for treating coronary heart disease
CN104645020A (en) Traditional Chinese medicine composition for treating coronary heart disease and angina and application of traditional Chinese medicine composition
CN104189288A (en) Traditional Chinese medicine composition for treating myocardial infarction and application of traditional Chinese medicine composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170606

Termination date: 20190311